188 related articles for article (PubMed ID: 38197895)
1. Clinical characteristics and prognosis of patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction.
Chen QF; Hu J; Hu J; Nijjar PS; Xu J; Shi S; Liang D; Liao H; Gao J; Lin WH; You S; Zhou XD
Clin Res Cardiol; 2024 May; 113(5):761-769. PubMed ID: 38197895
[TBL] [Abstract][Full Text] [Related]
2. Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy.
Liu J; Wang D; Ruan J; Wu G; Xu L; Jiang W; Wang J; Sun X; Kang L; Song L
BMC Med; 2022 Jan; 20(1):21. PubMed ID: 35078475
[TBL] [Abstract][Full Text] [Related]
3. Association Between Heart Failure With Preserved Left Ventricular Ejection Fraction and Impaired Left Atrial Phasic Function in Hypertrophic Cardiomyopathy: Evaluation by Cardiac MRI Feature Tracking.
Shi R; Shi K; Huang S; Li X; Xia CC; Li Y; He S; Li ZL; He Y; Guo YK; Yang ZG
J Magn Reson Imaging; 2022 Jul; 56(1):248-259. PubMed ID: 34799953
[TBL] [Abstract][Full Text] [Related]
4. Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.
Si J; Ding Z; Hu Y; Zhang X; Zhang Y; Cao H; Liu Y
J Cardiol; 2024 Apr; 83(4):250-257. PubMed ID: 37802201
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction.
Kalogeropoulos AP; Fonarow GC; Georgiopoulou V; Burkman G; Siwamogsatham S; Patel A; Li S; Papadimitriou L; Butler J
JAMA Cardiol; 2016 Aug; 1(5):510-8. PubMed ID: 27434402
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
Musumeci B; Tini G; Biagini E; Merlo M; Calore C; Ammirati E; Zampieri M; Russo D; Grilli G; Santolamazza C; Vio R; Rubino M; Ditaranto R; Del Franco A; Sormani P; Parisi V; Monda E; Francia P; Cipriani A; Limongelli G; Sinagra G; Olivotto I; Boni L; Autore C
Int J Cardiol; 2024 Apr; 400():131784. PubMed ID: 38242504
[TBL] [Abstract][Full Text] [Related]
8. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
[TBL] [Abstract][Full Text] [Related]
9. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
[No Abstract] [Full Text] [Related]
10. High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography.
Zhou XD; Chen QF; Targher G; Byrne CD; Shapiro MD; Tian N; Xiao T; Sung KC; Lip GYH; Zheng MH
J Am Heart Assoc; 2024 Feb; 13(3):e032997. PubMed ID: 38240197
[TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
Kroshian G; Joseph J; Kinlay S; Peralta AO; Hoffmeister PS; Singh JP; Yuyun MF
J Cardiovasc Electrophysiol; 2024 Apr; 35(4):715-726. PubMed ID: 38348517
[TBL] [Abstract][Full Text] [Related]
12. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
[TBL] [Abstract][Full Text] [Related]
13. Comparison Between Heart Failure Without Left Ventricular Systolic Dysfunction and Progression to End-Stage in Hypertrophic Cardiomyopathy.
Nakagawa S; Okada A; Irie Y; Moriuchi K; Amano M; Amaki M; Kanzaki H; Kusano K; Noguchi T; Kitai T; Izumi C
Circ J; 2024 Jun; ():. PubMed ID: 38910134
[TBL] [Abstract][Full Text] [Related]
14. Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction.
Gehlken C; Screever EM; Suthahar N; van der Meer P; Westenbrink BD; Coster JE; Van Veldhuisen DJ; de Boer RA; Meijers WC
ESC Heart Fail; 2021 Aug; 8(4):2458-2466. PubMed ID: 34085774
[TBL] [Abstract][Full Text] [Related]
15. Preclinical systolic dysfunction relating to ankle-brachial index among high-risk PAD population with preserved left ventricular ejection fraction.
Lin YH; Sung KT; Tsai CT; Lai YH; Lo CI; Yu FC; Lan WR; Hung TC; Kuo JY; Hou CJ; Yen CH; Peng MC; Yeh HI; Wu MT; Hung CL
Sci Rep; 2024 Mar; 14(1):6145. PubMed ID: 38480756
[TBL] [Abstract][Full Text] [Related]
16. Prognostic benefit of early diagnosis with exercise stress testing in heart failure with preserved ejection fraction.
Saito Y; Obokata M; Harada T; Kagami K; Wada N; Okumura Y; Ishii H
Eur J Prev Cardiol; 2023 Jul; 30(9):902-911. PubMed ID: 37094815
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics of heart failure with recovered ejection fraction].
Luo Y; Chai K; Cheng YL; Zhu WR; Li YY; Wang H; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):333-339. PubMed ID: 33874682
[No Abstract] [Full Text] [Related]
18. Mild and moderate to severe early acute kidney injury following cardiac surgery among patients with heart failure and preserved vs. mid-range vs. reduced ejection fraction: A retrospective cohort study.
Gao Y; Wang C; Li J; Ji B; Wang J; Yan F; Wang Y
Eur J Anaesthesiol; 2022 Aug; 39(8):673-684. PubMed ID: 35791895
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).
Farré N; Lupon J; Roig E; Gonzalez-Costello J; Vila J; Perez S; de Antonio M; Solé-González E; Sánchez-Enrique C; Moliner P; Ruiz S; Enjuanes C; Mirabet S; Bayés-Genís A; Comin-Colet J;
BMJ Open; 2017 Dec; 7(12):e018719. PubMed ID: 29273666
[TBL] [Abstract][Full Text] [Related]
20. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
